Delivery Order SPE2DB25D3005-SPE2DB25FQEDA
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,619.93 firm fixed price delivery order is for the supply of 100 milligram Celebrex capsules. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,269.15 firm fixed price delivery order is for the pharmaceutical product CELECOXIB 200MG 500S. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award to Amerisourcebergen Drug Corporation, through its Corporate Office division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a firm fixed price delivery order for the pharmaceutical product CELEBREX 200 MG CAPSULE 100S, with a ceiling value of $1,176.26 and a performance period through March 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,482.78, is for the delivery of 36,000 units of a 100-count capsule product. The contract type is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,379.24 firm fixed-price delivery order is for 24,000 units of a 100-count capsule product, with a completion date of May 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $762,206.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of January 29, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $555,186.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type and an ultimate completion date of March 12, 2024. The award is not set aside for any specific business type, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc.,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,786.06, is a Delivery Order with a Firm Fixed Price pricing type. The contract covers the supply of 4567828914 ! COBENFY 100 MG-20 MG CAPSULE 60S, a pharmaceutical product, with an ultimate completion date of April 8, 2025. This award is not associated with a set-aside designation....